TACE Combined With Lenvatinib for Unresectable Hepatocellular Carcinoma
Clinical trial NCT04490694 · UNKNOWN
Trial details
- NCT number
- NCT04490694
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-01
- Primary completion
- 2022-08-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.